IL PROPAFENONE NEL TRATTAMENTO ACUTO E NELLA PREVENZIONE DELLA TACHICARDIA PAROSSISTICA SOPRAVENTRICOLARE IN PAZIENTI CON SINDROME DI WOLFF-PARKINSON- WHITE

Translated title of the contribution: Propafenone in the acute treatment and prevention of paroxysmal supraventricular tachycardia in patients with Wolff-Parkinson-White syndrome

M. Palma, G. Palma, I. Oppo, M. M. Piscitelli, S. Nardi, E. Pisani, V. Santinelli

Research output: Contribution to journalArticle

Abstract

Propafenone is very effective in the control of paroxysmal supraventricular tachycardia in patients with Wolff-Parkinson-White syndrome; intravenous Propafenone can predict the efficacy of oral therapy. Propafenone administration is not associated with major side effects.

Original languageItalian
Pages (from-to)33-36
Number of pages4
JournalCuore
Volume12
Issue number1
Publication statusPublished - 1995

Fingerprint

Propafenone
Paroxysmal Tachycardia
Wolff-Parkinson-White Syndrome
Supraventricular Tachycardia
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

IL PROPAFENONE NEL TRATTAMENTO ACUTO E NELLA PREVENZIONE DELLA TACHICARDIA PAROSSISTICA SOPRAVENTRICOLARE IN PAZIENTI CON SINDROME DI WOLFF-PARKINSON- WHITE. / Palma, M.; Palma, G.; Oppo, I.; Piscitelli, M. M.; Nardi, S.; Pisani, E.; Santinelli, V.

In: Cuore, Vol. 12, No. 1, 1995, p. 33-36.

Research output: Contribution to journalArticle

Palma, M. ; Palma, G. ; Oppo, I. ; Piscitelli, M. M. ; Nardi, S. ; Pisani, E. ; Santinelli, V. / IL PROPAFENONE NEL TRATTAMENTO ACUTO E NELLA PREVENZIONE DELLA TACHICARDIA PAROSSISTICA SOPRAVENTRICOLARE IN PAZIENTI CON SINDROME DI WOLFF-PARKINSON- WHITE. In: Cuore. 1995 ; Vol. 12, No. 1. pp. 33-36.
@article{7162d6e8c85a490cbeb566555de5110e,
title = "IL PROPAFENONE NEL TRATTAMENTO ACUTO E NELLA PREVENZIONE DELLA TACHICARDIA PAROSSISTICA SOPRAVENTRICOLARE IN PAZIENTI CON SINDROME DI WOLFF-PARKINSON- WHITE",
abstract = "Propafenone is very effective in the control of paroxysmal supraventricular tachycardia in patients with Wolff-Parkinson-White syndrome; intravenous Propafenone can predict the efficacy of oral therapy. Propafenone administration is not associated with major side effects.",
keywords = "paroxysmal supraventricular tachycardia, Propafenone, Wolff-Parkinson-White syndrome",
author = "M. Palma and G. Palma and I. Oppo and Piscitelli, {M. M.} and S. Nardi and E. Pisani and V. Santinelli",
year = "1995",
language = "Italian",
volume = "12",
pages = "33--36",
journal = "Cuore",
issn = "1122-7176",
publisher = "Casa Editrice Scientifica Internazionale Periodici",
number = "1",

}

TY - JOUR

T1 - IL PROPAFENONE NEL TRATTAMENTO ACUTO E NELLA PREVENZIONE DELLA TACHICARDIA PAROSSISTICA SOPRAVENTRICOLARE IN PAZIENTI CON SINDROME DI WOLFF-PARKINSON- WHITE

AU - Palma, M.

AU - Palma, G.

AU - Oppo, I.

AU - Piscitelli, M. M.

AU - Nardi, S.

AU - Pisani, E.

AU - Santinelli, V.

PY - 1995

Y1 - 1995

N2 - Propafenone is very effective in the control of paroxysmal supraventricular tachycardia in patients with Wolff-Parkinson-White syndrome; intravenous Propafenone can predict the efficacy of oral therapy. Propafenone administration is not associated with major side effects.

AB - Propafenone is very effective in the control of paroxysmal supraventricular tachycardia in patients with Wolff-Parkinson-White syndrome; intravenous Propafenone can predict the efficacy of oral therapy. Propafenone administration is not associated with major side effects.

KW - paroxysmal supraventricular tachycardia

KW - Propafenone

KW - Wolff-Parkinson-White syndrome

UR - http://www.scopus.com/inward/record.url?scp=0029058663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029058663&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0029058663

VL - 12

SP - 33

EP - 36

JO - Cuore

JF - Cuore

SN - 1122-7176

IS - 1

ER -